Works matching IS 1383875X AND DT 2014 AND VI 41 AND IP 2


Results: 14
    1
    3

    Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.

    Published in:
    Journal of Interventional Cardiac Electrophysiology, 2014, v. 41, n. 2, p. 107, doi. 10.1007/s10840-014-9924-9
    By:
    • Naccarelli, Gerald;
    • Cappato, Riccardo;
    • Hohnloser, Stefan;
    • Marchlinski, Francis;
    • Wilber, David;
    • Xiang, Jim;
    • Ma, Changsheng;
    • Hess, Susanne;
    • Davies, David;
    • Fields, Larry;
    • Natale, Andrea
    Publication type:
    Article
    4
    5
    6

    Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation.

    Published in:
    Journal of Interventional Cardiac Electrophysiology, 2014, v. 41, n. 2, p. 129, doi. 10.1007/s10840-014-9922-y
    By:
    • Conte, Giulio;
    • Asmundis, Carlo;
    • Baltogiannis, Giannis;
    • Giovanni, Giacomo;
    • Ciconte, Giuseppe;
    • Sieira, Juan;
    • Saitoh, Yukio;
    • Wauters, Kristel;
    • Mugnai, Giacomo;
    • Julià, Justo;
    • Irfan, Ghazala;
    • Levinstein, Moises;
    • Cotino-Moreno, Hugo;
    • Chierchia, Gian-Battista;
    • Brugada, Pedro
    Publication type:
    Article
    7
    8
    9
    10
    11
    13
    14